Open AccessA safety analysis of different drug regimens used in human immunodeficiency virus-positive patients
Author(s) -
Nidhi Chauhan,
Samidh Shah,
Mira Desai,
Asha Shah
Publication year - 2018
Publication title -
indian journal of sexually transmitted diseases and aids
Language(s) - English
Resource type - Journals
eISSN - 2589-0565
pISSN - 2589-0557
DOI - 10.4103/ijstd.ijstd_116_17
Subject(s) - medicine , efavirenz , lamivudine , nevirapine , regimen , zidovudine , pharmacovigilance , abacavir , pediatrics , adverse effect , human immunodeficiency virus (hiv) , antiretroviral therapy , immunology , viral load , virus , viral disease , hepatitis b virus
Long-term toxicity of antiretroviral agents is rarely addressed in initial clinical trials. Effective pharmacovigilance is essential for long-term safety of antiretroviral therapy (ART).